A geospatial assessment of industrial releases and pediatric neuroblastic tumours at diagnosis: A retrospective case series

Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital i...

Full description

Saved in:
Bibliographic Details
Published inArchives of environmental & occupational health Vol. 78; no. 9-10; pp. 455 - 470
Main Authors Tambasco, Domenica, Franklin, Meredith, Harris, Shelley A., Tibout, Pauline, Doria, Andrea S.
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 2023
Kirkpatrick Jordon Foundation
Subjects
Online AccessGet full text
ISSN1933-8244
2154-4700
2154-4700
DOI10.1080/19338244.2023.2291734

Cover

Abstract Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations.
AbstractList Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (  = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (  = 0.02,  = 0.04, and  = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05,  = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations.
Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01–1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations.
Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations.Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship between industrial emissions and neuroblastic tumour diagnosis. A retrospective case series of 310 patients was evaluated at a tertiary hospital in Toronto, Canada between January 2008, and December 2018. Data from the National Pollutant Release Inventory (NPRI) were used to estimate exposure for a dozen chemicals with known or suspected carcinogenicity or embryotoxicity. Comparative analysis and predictive logistic regression models for malignant versus benign neuroblastic tumours included variables for residential proximity, number, and type of industries, mean total emissions within 2 km, and inverse distance weighted (IDW) quantity of chemical-specific industrial emissions estimated within 10 and 50 km of cases. No significant difference was seen between malignant and benign cases with respect to the mean nearest residential distance to industry, the number or type of industry, or the mean total quantity of industrial emissions within a 2 km radius of residential location of cases. However, there were statistically significant differences in the interpolated IDW emissions of dioxins and furans released between 1993 and 2019 within 10 km. Concentrations were significantly higher in malignant neuroblastic tumours at 1.65 grams (g) toxic equivalent (TEQ) (SD 2.01 g TEQ) compared to benign neuroblastic tumours at 1.13 g TEQ (SD 0.84 g TEQ) (p = 0.05). Within 50 km 3 years prior to diagnosis, malignant cases were exposed to higher levels of aluminum, benzene, and nitrogen dioxide (p = 0.02, p = 0.04, and p = 0.02 respectively). Regression analysis of the IDW emissions within a 50 km radius revealed higher odds of exposure to benzene for malignant neuroblastic tumours (OR = 1.03, CI: 1.01-1.05, p = 0.01). These preliminary findings suggest a potential role of industrial emissions in the development of malignant pediatric neuroblastic tumours and underscore the need for further research to investigate these associations.
Author Franklin, Meredith
Tambasco, Domenica
Tibout, Pauline
Doria, Andrea S.
Harris, Shelley A.
Author_xml – sequence: 1
  givenname: Domenica
  surname: Tambasco
  fullname: Tambasco, Domenica
  organization: Department of Family and Community Medicine, Women's College Hospital, Environmental Health Clinic and University of Toronto
– sequence: 2
  givenname: Meredith
  surname: Franklin
  fullname: Franklin, Meredith
  organization: Department of Statistical Sciences and School of the Environment, University of Toronto
– sequence: 3
  givenname: Shelley A.
  surname: Harris
  fullname: Harris, Shelley A.
  organization: Divisions of Epidemiology & Occupational and Environmental Health, Dalla Lana School of Public Health
– sequence: 4
  givenname: Pauline
  surname: Tibout
  fullname: Tibout, Pauline
  organization: Division of Hematology and Oncology, The Hospital for Sick Children
– sequence: 5
  givenname: Andrea S.
  surname: Doria
  fullname: Doria, Andrea S.
  organization: Department of Diagnostic Imaging, Research Institute, The Hospital for Sick Children and Department of Medical Imaging, University of Toronto
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38190263$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9v1DAQxS1URLcLHwFkiQuXLPbY-ceJVQUUqRIXOFuzzqRyldiL7YAqvjyOdsuBQ0-W_X4z4zfvil344Imx11LspOjEe9kr1YHWOxCgdgC9bJV-xjYga13pVogLtlmZaoUu2VVK90LoFnp4wS5VJ3sBjdqwP3t-RyEdMTucOKZEKc3kMw8jd35YUo6rEGkiLBpHP_AjDQ7Lu-WelhgOE6ZcLnmZwxILknnR73xILn3g-1KbY5lANrtfxG1pwxNFR-klez7ilOjV-dyyH58_fb--qW6_ffl6vb-trNKQKwTsirtmqKkehWqxB00koR1Hawm1laNShI1WiMWiJDgoICVl06OsYVBb9u7U9xjDz4VSNrNLlqYJPYUlmbI7qKGWbV3Qt_-h98WTL78rFCgQXVN2umVvztRymGkwx-hmjA_mca0FqE-ALc5TpPEfIoVZ4zOP8Zk1PnOOr9R9PNU5P4Y44-8Qp8FkfJhCHCN665JRT7f4CzOaocs
Cites_doi 10.1371/journal.pbio.2002800
10.1186/1476-072X-3-28
10.1186/s13046-022-02281-w
10.1080/10408444.2020.1801575
10.1007/s11004-008-9211-3
10.1016/B978-0-12-802916-9.00010-5
10.1016/j.reprotox.2017.06.044
10.1503/cmaj.071783
10.1080/08880018.2021.1979147
10.1097/00001648-200101000-00005
10.1136/jech.2004.031674
10.1097/MPH.0000000000000416
10.3390/ijerph6123190
10.3389/fnmol.2019.00009
10.3390/ijerph15081625
10.1016/B978-0-12-819092-0.00014-5
10.1016/j.envint.2016.04.023
10.1542/peds.2012-2757
10.1136/archdischild-2017-314032
10.1097/MPH.0b013e3181bcc809
10.1097/EDE.0000000000001156
10.1080/00039899909602220
10.1016/j.envres.2017.03.009
10.1157/13076768
10.1016/j.tox.2007.10.012
10.1177/019262330002800125
10.1007/s10552-018-1011-6
10.1002/cncr.20910
10.1016/j.cppeds.2016.08.004
10.1186/1476-069X-10-S1-S8
10.1111/j.1365-3016.2008.00983.x
10.1016/j.envres.2013.09.002
10.1097/MOP.0b013e32832925cc
10.1023/a:1008951632482
10.1093/carcin/bgr297
10.1038/bjc.2014.358
10.3390/ijerph15030505
10.1016/j.pedhc.2021.05.005
10.1016/j.freeradbiomed.2010.07.028
10.1186/s13104-021-05506-x
10.26444/aaem/94299
10.1007/s00381-011-1483-0
10.1136/jech.2004.021675
10.1080/00039896.1993.9938369
10.1093/aje/154.2.106
10.22541/au.165486268.87677869/v1
10.6091/ibj.1230.2013
10.1093/aje/kwv120
10.1016/0378-4274(81)90024-2
ContentType Journal Article
Copyright 2024 Taylor & Francis Group, LLC 2024
2024 Taylor & Francis Group, LLC
Copyright_xml – notice: 2024 Taylor & Francis Group, LLC 2024
– notice: 2024 Taylor & Francis Group, LLC
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1080/19338244.2023.2291734
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Occupational Therapy & Rehabilitation
EISSN 2154-4700
EndPage 470
ExternalDocumentID 38190263
10_1080_19338244_2023_2291734
2291734
Genre Research Article
Journal Article
GroupedDBID -~X
.7F
.QJ
0BK
0R~
23N
30N
354
36B
4.4
4P2
53G
5GY
6J9
7X7
8F7
AAENE
AAIKC
AAJMT
AALDU
AAMIU
AAMNW
AAPUL
AAQRR
ABCCY
ABDBF
ABFIM
ABJNI
ABLIJ
ABPAQ
ABPEM
ABTAI
ABXUL
ABXYU
ACGFS
ACGOD
ACTIO
ACUHS
ADCVX
ADGTB
AEGXH
AEISY
AENEX
AEOZL
AEPSL
AEYOC
AFRAH
AGDLA
AGMYJ
AHDZW
AHMBA
AIJEM
AKBVH
AKOOK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AQRUH
AVBZW
AWYRJ
B0M
BENPR
BLEHA
CCCUG
CS3
DGEBU
DKSSO
EAP
EAS
EBB
EBC
EBD
EBS
EDH
EHB
EHE
EHN
EMB
EMK
EMOBN
EPL
EPT
ESX
E~A
E~B
F5P
GTTXZ
GUQSH
H13
HCIFZ
HF~
HZ~
H~9
H~P
IPNFZ
J.P
KYCEM
L7B
LJTGL
M0R
M2O
M2P
M4Z
NA5
NX0
O9-
OHH
OVD
QN7
Q~Q
RIG
RNANH
ROSJB
RTWRZ
S-T
SNACF
SV3
TBQAZ
TDBHL
TEI
TEORI
TFL
TFT
TFW
TQWBC
TTHFI
TUROJ
TUS
UT5
UU3
VVN
WH7
ZGOLN
ZY1
~8M
~S~
AAGDL
AAHIA
AAYXX
ADYSH
AFRVT
AIYEW
AMPGV
CITATION
EBX
7XC
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
AAGME
ABFMO
ABRLO
ABUWG
ACBNA
ACDHJ
ACZPZ
ADBBV
ADOPC
AEUYN
AFKRA
ATCPS
AURDB
AZQEC
BCR
BCU
BEC
BES
BFWEY
BHPHI
BKNYI
BLC
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
CWRZV
DWQXO
ECM
EIF
EJD
FYUFA
GNUQQ
HMCUK
K9-
M1P
M2Q
NPM
NUSFT
OHT
P-O
PATMY
PCLFJ
PEA
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PYCSY
QF4
QM4
QO4
S0X
SJFOW
TASJS
UKHRP
ZE2
ZXP
K9.
7X8
ID FETCH-LOGICAL-c342t-a2a89176d5e5f037a924ee127ffccea4c1f33ea643aa0041e2b32e31169a152d3
ISSN 1933-8244
2154-4700
IngestDate Fri Sep 05 09:35:03 EDT 2025
Mon Jul 14 10:42:46 EDT 2025
Mon Jul 21 06:00:29 EDT 2025
Tue Jul 01 02:56:10 EDT 2025
Wed Dec 25 09:06:54 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9-10
Keywords neuroblastoma
industrial
ganglioneuroblastoma
geospatial
Emissions
pediatric
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c342t-a2a89176d5e5f037a924ee127ffccea4c1f33ea643aa0041e2b32e31169a152d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 38190263
PQID 2923208693
PQPubID 28654
PageCount 16
ParticipantIDs informaworld_taylorfrancis_310_1080_19338244_2023_2291734
pubmed_primary_38190263
crossref_primary_10_1080_19338244_2023_2291734
proquest_miscellaneous_2912525175
proquest_journals_2923208693
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-00-00
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – year: 2023
  text: 2023-00-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle Archives of environmental & occupational health
PublicationTitleAlternate Arch Environ Occup Health
PublicationYear 2023
Publisher Taylor & Francis
Kirkpatrick Jordon Foundation
Publisher_xml – name: Taylor & Francis
– name: Kirkpatrick Jordon Foundation
References e_1_3_4_3_1
e_1_3_4_61_1
e_1_3_4_63_1
e_1_3_4_9_1
e_1_3_4_42_1
e_1_3_4_7_1
e_1_3_4_40_1
e_1_3_4_5_1
e_1_3_4_23_1
e_1_3_4_46_1
e_1_3_4_69_1
e_1_3_4_21_1
e_1_3_4_44_1
e_1_3_4_27_1
e_1_3_4_65_1
e_1_3_4_25_1
e_1_3_4_48_1
e_1_3_4_67_1
e_1_3_4_29_1
National Research Council (US). (e_1_3_4_72_1) 2007
e_1_3_4_74_1
e_1_3_4_53_1
e_1_3_4_30_1
e_1_3_4_51_1
e_1_3_4_70_1
e_1_3_4_13_1
e_1_3_4_34_1
e_1_3_4_59_1
e_1_3_4_11_1
e_1_3_4_32_1
e_1_3_4_17_1
e_1_3_4_38_1
e_1_3_4_15_1
e_1_3_4_36_1
e_1_3_4_57_1
e_1_3_4_19_1
e_1_3_4_4_1
e_1_3_4_2_1
e_1_3_4_62_1
e_1_3_4_64_1
e_1_3_4_8_1
e_1_3_4_20_1
e_1_3_4_41_1
e_1_3_4_6_1
e_1_3_4_60_1
e_1_3_4_24_1
e_1_3_4_45_1
e_1_3_4_22_1
e_1_3_4_43_1
e_1_3_4_28_1
e_1_3_4_49_1
e_1_3_4_66_1
e_1_3_4_26_1
e_1_3_4_47_1
e_1_3_4_68_1
Centre for Surveillance and Applied Research, Public Health Agency of Canada (e_1_3_4_55_1) 2023
e_1_3_4_73_1
e_1_3_4_75_1
e_1_3_4_31_1
e_1_3_4_52_1
e_1_3_4_50_1
e_1_3_4_71_1
e_1_3_4_12_1
e_1_3_4_35_1
e_1_3_4_58_1
e_1_3_4_10_1
e_1_3_4_33_1
e_1_3_4_54_1
e_1_3_4_16_1
e_1_3_4_39_1
e_1_3_4_14_1
e_1_3_4_37_1
e_1_3_4_56_1
e_1_3_4_18_1
References_xml – ident: e_1_3_4_70_1
  doi: 10.1371/journal.pbio.2002800
– ident: e_1_3_4_36_1
– ident: e_1_3_4_39_1
  doi: 10.1186/1476-072X-3-28
– ident: e_1_3_4_61_1
  doi: 10.1186/s13046-022-02281-w
– ident: e_1_3_4_60_1
  doi: 10.1080/10408444.2020.1801575
– ident: e_1_3_4_52_1
– ident: e_1_3_4_13_1
  doi: 10.1007/s11004-008-9211-3
– ident: e_1_3_4_15_1
  doi: 10.1016/B978-0-12-802916-9.00010-5
– ident: e_1_3_4_66_1
– ident: e_1_3_4_12_1
  doi: 10.1016/j.reprotox.2017.06.044
– ident: e_1_3_4_14_1
  doi: 10.1503/cmaj.071783
– ident: e_1_3_4_22_1
  doi: 10.1080/08880018.2021.1979147
– ident: e_1_3_4_74_1
– ident: e_1_3_4_26_1
  doi: 10.1097/00001648-200101000-00005
– ident: e_1_3_4_49_1
– ident: e_1_3_4_27_1
  doi: 10.1136/jech.2004.031674
– ident: e_1_3_4_35_1
  doi: 10.1097/MPH.0000000000000416
– ident: e_1_3_4_68_1
  doi: 10.3390/ijerph6123190
– ident: e_1_3_4_51_1
– ident: e_1_3_4_62_1
  doi: 10.3389/fnmol.2019.00009
– ident: e_1_3_4_6_1
– ident: e_1_3_4_3_1
– ident: e_1_3_4_11_1
  doi: 10.3390/ijerph15081625
– ident: e_1_3_4_37_1
– ident: e_1_3_4_59_1
  doi: 10.1016/B978-0-12-819092-0.00014-5
– ident: e_1_3_4_63_1
  doi: 10.1016/j.envint.2016.04.023
– ident: e_1_3_4_34_1
  doi: 10.1542/peds.2012-2757
– ident: e_1_3_4_19_1
  doi: 10.1136/archdischild-2017-314032
– ident: e_1_3_4_31_1
  doi: 10.1097/MPH.0b013e3181bcc809
– ident: e_1_3_4_56_1
– ident: e_1_3_4_16_1
  doi: 10.1097/EDE.0000000000001156
– ident: e_1_3_4_48_1
– ident: e_1_3_4_53_1
– volume-title: Cancer in Young People in Canada Data Tool. 2020 Edition. Public Health Infobase
  year: 2023
  ident: e_1_3_4_55_1
– ident: e_1_3_4_9_1
  doi: 10.1080/00039899909602220
– ident: e_1_3_4_64_1
  doi: 10.1016/j.envres.2017.03.009
– ident: e_1_3_4_20_1
  doi: 10.1157/13076768
– ident: e_1_3_4_43_1
  doi: 10.1016/j.tox.2007.10.012
– ident: e_1_3_4_10_1
  doi: 10.1177/019262330002800125
– ident: e_1_3_4_30_1
  doi: 10.1007/s10552-018-1011-6
– volume-title: Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology. Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment
  year: 2007
  ident: e_1_3_4_72_1
– ident: e_1_3_4_75_1
– ident: e_1_3_4_2_1
  doi: 10.1002/cncr.20910
– ident: e_1_3_4_69_1
  doi: 10.1016/j.cppeds.2016.08.004
– ident: e_1_3_4_71_1
  doi: 10.1186/1476-069X-10-S1-S8
– ident: e_1_3_4_18_1
  doi: 10.1111/j.1365-3016.2008.00983.x
– ident: e_1_3_4_47_1
– ident: e_1_3_4_42_1
  doi: 10.1016/j.envres.2013.09.002
– ident: e_1_3_4_17_1
  doi: 10.1097/MOP.0b013e32832925cc
– ident: e_1_3_4_41_1
  doi: 10.1023/a:1008951632482
– ident: e_1_3_4_58_1
  doi: 10.1093/carcin/bgr297
– ident: e_1_3_4_50_1
– ident: e_1_3_4_25_1
  doi: 10.1038/bjc.2014.358
– ident: e_1_3_4_38_1
– ident: e_1_3_4_32_1
  doi: 10.3390/ijerph15030505
– ident: e_1_3_4_23_1
  doi: 10.1016/j.pedhc.2021.05.005
– ident: e_1_3_4_73_1
– ident: e_1_3_4_5_1
– ident: e_1_3_4_40_1
  doi: 10.1016/j.freeradbiomed.2010.07.028
– ident: e_1_3_4_54_1
– ident: e_1_3_4_46_1
– ident: e_1_3_4_67_1
  doi: 10.1186/s13104-021-05506-x
– ident: e_1_3_4_21_1
  doi: 10.26444/aaem/94299
– ident: e_1_3_4_29_1
  doi: 10.1007/s00381-011-1483-0
– ident: e_1_3_4_28_1
  doi: 10.1136/jech.2004.021675
– ident: e_1_3_4_8_1
  doi: 10.1080/00039896.1993.9938369
– ident: e_1_3_4_65_1
– ident: e_1_3_4_33_1
  doi: 10.1093/aje/154.2.106
– ident: e_1_3_4_24_1
  doi: 10.22541/au.165486268.87677869/v1
– ident: e_1_3_4_7_1
– ident: e_1_3_4_4_1
– ident: e_1_3_4_44_1
  doi: 10.6091/ibj.1230.2013
– ident: e_1_3_4_57_1
  doi: 10.1093/aje/kwv120
– ident: e_1_3_4_45_1
  doi: 10.1016/0378-4274(81)90024-2
SSID ssj0047292
Score 2.3235724
Snippet Environmental risk factors associated with malignancy of pediatric neuroblastic tumours are not well-known and few studies have examined the relationship...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Publisher
StartPage 455
SubjectTerms Aluminum
Benzene
Carcinogenicity
Carcinogens
Child
Comparative analysis
Diagnosis
Dioxins
Emissions
Environmental Pollutants
Environmental risk
Exposure
Furans
ganglioneuroblastoma
geospatial
Humans
Hydrocarbons
industrial
Industrial emissions
Malignancy
Neoplasms
neuroblastoma
Nitrogen dioxide
pediatric
Pediatrics
Pesticides
Regression analysis
Regression models
Residential location
Retrospective Studies
Risk factors
Statistical analysis
Tumors
Title A geospatial assessment of industrial releases and pediatric neuroblastic tumours at diagnosis: A retrospective case series
URI https://www.tandfonline.com/doi/abs/10.1080/19338244.2023.2291734
https://www.ncbi.nlm.nih.gov/pubmed/38190263
https://www.proquest.com/docview/2923208693
https://www.proquest.com/docview/2912525175
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZKV1rtBcHyKizISMClSknsNA9uFQ9VSMsBumLFJXKTCeqhTdWmh11-En-SmdhOXNEVj0tUxbWddj7ZM8433zD2oggAQ64g9yBXVMKsKLw0HSdeWMQQSQpCVMPy_RRNL8KPl-PLXu-nw1ra1fNRfn0wr-R_rIr30K6UJfsPlm0HxRv4Ge2LV7QwXv_KxpPhd6i2xImmjP9WY1PLQLQlOagsCu5VWox5bUtzDBslyzk6zyTZWu-WOOGWUhsLTb5bbHXS-gbqTWXzMYc5DjSk32aohwf0a53UOZyckFW5SsY68bI7MFjiPppX2pfHPg51yK0nf04lRRddv6nabLQ6wpeGyXrVncnOFsS1tqxHSxswBxs663gEzdKHfkjohbHvu-t0nDh4TD3DhtXrbqi1fn_bDzSBEp1UmaAfM6JpRkJgiKpPUB2MrJcNSCiAxbBUdttjS1q0TbfYkYijSPTZ0WT67ttXu_GHGKcImySW-K8PznrCju04e57Qnk7uzdFO4_XM7rDbJlzhE429u6wHq1N2fG4IGafspatSzWdaooK_4p_3BODvsR8T3kGVd1DlVck7qHILVY5Q5S1UuQtVbqDKVc1bqL7hE74HVE5A5Rqo99nFh_ezt1PP1P3wchmK2lNCJfhnRcUYxqUvY5WKECAQcVnmOagwD0opQaEvrRTpxYGYSwEyCKJUoTtayAesv6pW8IhxH5LCj6O0wIFDBTCPFaDPS3tVKZMiHbCRtUG21vIuWWBUc639MrJfZuw3YKlrqaxuztVKXQQnk3_oe2bNmplVZJshZqTwkyiVA_a8bcY1nl7cqRVUO_oOhiGkLTgesIcaDu3TWjQ9vrHlCTuhp9DnhmesX2928BQ96Xr-zCD4F3aqy3w
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BkaAXHuXRhQJGAm4JGztPbitEtUC7B7SVerMce4IqxKZqshf488zE8WoXqeLQc2xr7IxnvrHH3wC8dQlSyJXYCK3hEmbORVWVlVHqCswVByFmyPJd5POz9Ot5dr71FobTKjmGbjxRxGCreXPzYXRIiftAoEOV5Jdirv0dS0khh0pvw52M4Din9anpIljjlMCj9DfLKuI-4RXPdcPs-Kcd9tLrMejgi44fgA2z8CkoP-N1X8f29z8Ejzeb5kO4P0JVMfO69Qhu4eoA7p6Ol_EH8G6boVgsPT2BeC--75B_P4Y_M_ED245bUjuzoQIVbSMuNpVDBFdvIZfaCRJYXIYKImIg3KwJ45MUol__IqmoSS-czxG86D6KGfXtr9rwaFRYGkbw1sLuCZwdf15-mkdjzYfIqlT2kZGmpHnmLsOsmarCUHyImMiiaaxFk9qkUQoN4ShjmCsMZa0kqiTJK0NQxKmnsLdqV3gIYoqlmxZ55Wjg1CDWhUHCO2ynGlW6agJx-NP60lN76GRkTA1Lr3np9bj0E6i29UH3w5lK4wugaPWfvkdBefRoJTpNqqkkxZSVmsCbzWfa33xpY1bYrrkNQVDmlcsm8Mwr3UZajrYphlbPbyDYa7g3X56e6JMvi28vYJ8_-ROmI9jrr9b4kjBXX78aNtVfUc0f0w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BkSouPMproYCRgFvSxJMntxWwKq8VQq3EzXLiMaoQm1WTvcCfZxzHqy5SxaFnPzR2xjPfxONvAF6alDjkStuIWu1KmBkT1XVeRZkpqUAXhOgxy3dZHJ9mH7_nIZuwn9IqXQxtPVHEaKvd4V4bGzLijhhzYMVuKXalv2MpOeLA7DrcKBKsHX0-JstgjDPGjtJfLGPkxoRHPJdNs-OedshLL4egoyta3IYmLMJnoPyMN0MTt7__4Xe80irvwK0JqIq516y7cI1WB7D_ZbqKP4BXF_mJxYknJxCvxbcd6u978GcuflDXu57cT2-JQEVnxdm2bohwtVvYofaC5RXrUD9EjHSbDSN8lkIMm18sFXcZhPEZgmf9GzHnscN5F56MipanEe5gUX8fThfvT94eR1PFh6jFTA6RlrridRYmp9wmWGqODolSWVrbtqSzNrWIpBlFae2Ywkg2KAnTtKg1AxGDD2Bv1a3oEYiEKpOURW144kwTNaUmRjvOSlmsTD2DOHxotfbEHiqd-FLD1iu39Wra-hnUF9VBDeMfFevLnyj8z9jDoDtqshG9Ys1EyRFljTN4sW3m0-2ubPSKuo3rwwDUscrlM3jodW4rrYu1OYLGx1cQ7Dnsf323UJ8_LD89gZuuxf9eOoS94XxDTxlwDc2z8Uj9BclUHoA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+geospatial+assessment+of+industrial+releases+and+pediatric+neuroblastic+tumours+at+diagnosis%3A+A+retrospective+case+series&rft.jtitle=Archives+of+environmental+%26+occupational+health&rft.au=Tambasco%2C+Domenica&rft.au=Franklin%2C+Meredith&rft.au=Harris%2C+Shelley+A&rft.au=Tibout%2C+Pauline&rft.date=2023&rft.eissn=2154-4700&rft.volume=78&rft.issue=9-10&rft.spage=455&rft_id=info:doi/10.1080%2F19338244.2023.2291734&rft_id=info%3Apmid%2F38190263&rft.externalDocID=38190263
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1933-8244&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1933-8244&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1933-8244&client=summon